Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quercetin in beta thalassemia major
IRCT201701172709N43Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of quercetin in beta thalassemia major, sponsored by Iran University of Medical Sciences. Started Mar 2017; status: completed.
02
Drugs
quercetin
03
Conditions
beta thalassemia major
Beyond the preview
Go deeper on IRCT201701172709N43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201701172709N43.